169
Participants
Start Date
May 31, 2005
Primary Completion Date
August 31, 2007
Study Completion Date
January 31, 2011
Temsirolimus (CCI-779)
Temsirolimus 175 mg IV once a week for 3 weeks; followed by 75 mg IV once a week
Temsirolimus (CCI-779)
Temsirolimus 175 mg IV once a week for 3 weeks; followed by 25 mg IV once a week
Investigator's choice
"Any of the following single agent treatments:~1. Fludarabine 25 mg/m2 IV over 30 minutes daily for 5 consecutive days, every 28 days or oral administration, as appropriate.~2. Chlorambucil 0.1 (0.1-0.2) mg/kg PO daily for 3 to 6 weeks as required OR 0.4 (0.3 0.8) mg/kg PO every 21 to 28 days~3. Gemcitabine 1 gm/m2 IV over 30 minutes on days 1, 8 and 15 every 28 days or day 1 and day 8 every 21 days~4. Cyclophosphamide 300 (200-450) mg/m2 PO daily for 5 consecutive days every 21 to 28 days, OR 600 (400-1200) mg/m2 IV every 21 to 28 days~5. Cladribine 5 mg/m2 IV daily for 5 consecutive days, every 28 days for 2-6 cycles depending on response,~6. Etoposide 50 (50-150) mg/m2 IV daily for 3-5 days every 21 to 28 days OR 100 (50 300) mg/m2 PO daily for 3-5 days every 21 to 28 days~7. Prednisone 40 (20-60) mg/m2 PO daily or every other day~8. Dexamethasone 20(20-40) mg PO/IV daily for 5 consecutive days, every 14 - 28 day"
Pfizer Investigational Site, East Melbourne
Pfizer Investigational Site, Leuven
Pfizer Investigational Site, Córdoba
Pfizer Investigational Site, Aarau
Pfizer Investigational Site, Bruges
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Ghent
Pfizer Investigational Site, Buffalo
Pfizer Investigational Site, Upland
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Milan
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Pamplona
Pfizer Investigational Site, Boca Raton
Pfizer Investigational Site, Bologna
Pfizer Investigational Site, Mainz
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Strasbourg
Pfizer Investigational Site, Lyon
Pfizer Investigational Site, Heidelberg
Pfizer Investigational Site, Pierre-Bénite
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Paris
Pfizer Investigational Site, Grapevine
Pfizer Investigational Site, Temple
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Ulm
Pfizer Investigational Site, Ulm
Pfizer Investigational Site, Fountain Valley
Pfizer Investigational Site, Villejuif
Pfizer Investigational Site, Catania
Pfizer Investigational Site, Honolulu
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Shanghai
Pfizer Investigational Site, Los Angeles
Pfizer Investigational Site, New Milford
Pfizer Investigational Site, Morristown
Pfizer Investigational Site, New York
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Vienna
Pfizer Investigational Site, Vila Buarque
Pfizer Investigational Site, Porto Alegre - RS
Pfizer Investigational Site, Edmonton
Pfizer Investigational Site, Vancouver
Pfizer Investigational Site, London
Pfizer Investigational Site, Ottawa
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Greenfield Park
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Providencia
Pfizer Investigational Site, Roma
Pfizer Investigational Site, Rotterdam
Pfizer Investigational Site, Lublin
Pfizer Investigational Site, Warsaw
Pfizer Investigational Site, Barcelona
Pfizer Investigational Site, L'Hospitalet de Llobregat
Pfizer Investigational Site, Lund
Pfizer Investigational Site, Uppsala
Pfizer Investigational Site, Plymouth
Pfizer Investigational Site, Southampton
Pfizer Investigational Site, Tooting
Pfizer Investigational Site, Sutton
Lead Sponsor
Pfizer
INDUSTRY